| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.002 | 0.926 | 5 Hydroxytryptamine uptake inhibitor | 0.81 0.003 CHEMBL255839 0.76 0.003 CHEMBL4525799 0.437 0.005 CHEMBL3526616 | ||
| 0.894 | 0.002 | 0.894 | Adrenaline uptake inhibitor | 0.762 0.002 CHEMBL255839 0.71 0.002 CHEMBL4525799 0.458 0.004 CHEMBL3526616 | ||
| 0.71 | 0.003 | 0.71 | Sigma receptor agonist | 0.686 0.003 CHEMBL255839 0.662 0.003 CHEMBL4525799 0.55 0.006 CHEMBL3526616 | ||
| 0.539 | 0.039 | 0.575 | Analgesic | 0.242 0.189 CHEMBL255839 0.575 0.031 CHEMBL4525799 0.413 0.079 CHEMBL3526616 | CHEMBL4525799 | |
| 0.415 | 0.003 | 0.415 | Dopamine transporter inhibitor | 0.281 0.004 CHEMBL255839 0.211 0.004 CHEMBL4525799 0.103 0.011 CHEMBL3526616 | ||
| 0.365 | 0.004 | 0.365 | Dopamine uptake inhibitor | 0.181 0.007 CHEMBL255839 0.117 0.015 CHEMBL4525799 | ||
| 0.342 | 0.005 | 0.342 | NMDA receptor antagonist | 0.197 0.015 CHEMBL255839 0.222 0.011 CHEMBL4525799 | ||
| 0.335 | 0.005 | 0.335 | Opioid kappa receptor antagonist | 0.314 0.005 CHEMBL255839 0.305 0.005 CHEMBL4525799 0.112 0.027 CHEMBL3526616 | ||
| 0.315 | 0.004 | 0.315 | NMDA 2A receptor antagonist | 0.157 0.006 CHEMBL255839 0.099 0.013 CHEMBL4525799 | ||
| 0.309 | 0.029 | 0.309 | Tyrosine 3 hydroxylase inhibitor | 0.308 0.029 CHEMBL255839 0.236 0.082 CHEMBL4525799 | ||
| 0.283 | 0.011 | 0.283 | Glutamate receptor antagonist | 0.152 0.05 CHEMBL255839 0.181 0.032 CHEMBL4525799 | ||
| 0.309 | 0.04 | 0.367 | 5 Hydroxytryptamine uptake stimulant | 0.367 0.021 CHEMBL255839 0.188 0.178 CHEMBL4525799 | CHEMBL255839 | |
| 0.271 | 0.006 | 0.271 | Opioid antagonist | 0.224 0.01 CHEMBL255839 0.228 0.01 CHEMBL4525799 0.135 0.03 CHEMBL3526616 | ||
| 0.267 | 0.005 | 0.267 | NMDA 2 receptor antagonist | 0.105 0.029 CHEMBL255839 0.153 0.016 CHEMBL4525799 | ||
| 0.305 | 0.049 | 0.305 | Superoxide dismutase inhibitor | 0.248 0.075 CHEMBL255839 0.176 0.146 CHEMBL4525799 | ||
| 0.318 | 0.064 | 0.366 | Spasmolytic | 0.216 0.108 CHEMBL255839 0.224 0.103 CHEMBL4525799 0.366 0.048 CHEMBL3526616 | CHEMBL3526616 | |
| 0.267 | 0.028 | 0.267 | Lipocortins synthesis antagonist | 0.205 0.053 CHEMBL255839 0.226 0.042 CHEMBL4525799 0.201 0.055 CHEMBL3526616 | ||
| 0.226 | 0.004 | 0.226 | NMDA receptor subunit 3B antagonist | 0.065 0.017 CHEMBL255839 0.052 0.023 CHEMBL4525799 | ||
| 0.229 | 0.008 | 0.229 | Analgesic, opioid | 0.085 0.042 CHEMBL255839 0.141 0.017 CHEMBL4525799 0.102 0.03 CHEMBL3526616 | ||
| 0.224 | 0.004 | 0.224 | NMDA receptor subunit 3A antagonist | 0.064 0.016 CHEMBL255839 0.054 0.018 CHEMBL4525799 | ||
| 0.22 | 0.017 | 0.221 | GABA C receptor agonist | 0.221 0.017 CHEMBL255839 0.095 0.072 CHEMBL4525799 | CHEMBL255839 | |
| 0.197 | 0.009 | 0.197 | Opioid mu receptor antagonist | 0.169 0.014 CHEMBL255839 0.163 0.015 CHEMBL4525799 0.097 0.033 CHEMBL3526616 | ||
| 0.266 | 0.082 | 0.42 | 5 Hydroxytryptamine release stimulant | 0.42 0.042 CHEMBL255839 | CHEMBL255839 | |
| 0.253 | 0.071 | 0.253 | 5 Hydroxytryptamine 1E antagonist | 0.176 0.159 CHEMBL255839 | ||
| 0.259 | 0.087 | 0.274 | Ca(v)3.3 blocker | 0.274 0.068 CHEMBL255839 0.262 0.083 CHEMBL4525799 | CHEMBL255839 | |
| 0.183 | 0.014 | 0.183 | Opioid delta receptor antagonist | 0.133 0.023 CHEMBL255839 0.123 0.025 CHEMBL4525799 0.06 0.046 CHEMBL3526616 | ||
| 0.227 | 0.061 | 0.275 | Anesthetic general | 0.15 0.113 CHEMBL4525799 0.275 0.04 CHEMBL3526616 | CHEMBL3526616 | |
| 0.159 | 0.006 | 0.159 | NMDA 2C receptor antagonist | 0.069 0.034 CHEMBL255839 0.108 0.013 CHEMBL4525799 | ||
| 0.172 | 0.02 | 0.261 | GABA C receptor antagonist | 0.261 0.005 CHEMBL255839 | CHEMBL255839 | |
| 0.237 | 0.088 | 0.304 | Interleukin agonist | 0.304 0.046 CHEMBL3526616 | CHEMBL3526616 | |
| 0.219 | 0.071 | 0.219 | Anticonvulsant | 0.156 0.122 CHEMBL255839 0.148 0.131 CHEMBL4525799 | ||
| 0.272 | 0.136 | 0.358 | GABA C receptor rho-3 antagonist | 0.358 0.082 CHEMBL255839 | CHEMBL255839 | |
| 0.139 | 0.005 | 0.139 | 5 Hydroxytryptamine 2C agonist | 0.135 0.005 CHEMBL255839 | ||
| 0.17 | 0.041 | 0.17 | Anesthetic local | 0.116 0.07 CHEMBL4525799 | ||
| 0.218 | 0.091 | 0.218 | Neuropeptide Y2 antagonist | 0.199 0.12 CHEMBL255839 | ||
| 0.194 | 0.083 | 0.2 | Psychostimulant | 0.2 0.08 CHEMBL255839 | CHEMBL255839 | |
| 0.129 | 0.025 | 0.129 | ABCA1 expression enhancer | 0.129 0.025 CHEMBL255839 0.103 0.047 CHEMBL4525799 | ||
| 0.307 | 0.204 | 0.309 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.309 0.201 CHEMBL255839 | CHEMBL255839 | |
| 0.221 | 0.118 | 0.248 | Gastrin inhibitor | 0.248 0.082 CHEMBL255839 | CHEMBL255839 | |
| 0.131 | 0.031 | 0.163 | Prolactin inhibitor | 0.118 0.04 CHEMBL255839 0.163 0.018 CHEMBL4525799 | CHEMBL4525799 | |
| 0.102 | 0.005 | 0.102 | Neurokinin 3 antagonist | 0.07 0.013 CHEMBL255839 0.079 0.009 CHEMBL4525799 | ||
| 0.247 | 0.151 | 0.247 | Calcium channel activator | |||
| 0.099 | 0.005 | 0.099 | Factor XIa inhibitor | 0.098 0.005 CHEMBL255839 | ||
| 0.139 | 0.046 | 0.146 | Papain-like protease (SARS coronavirus) inhibitor | 0.146 0.038 CHEMBL255839 | CHEMBL255839 | |
| 0.1 | 0.011 | 0.1 | Neurokinin antagonist | 0.06 0.025 CHEMBL255839 0.055 0.028 CHEMBL4525799 | ||
| 0.098 | 0.014 | 0.098 | Opioid agonist | 0.085 0.017 CHEMBL4525799 | ||
| 0.109 | 0.032 | 0.109 | Porphobilinogen synthase inhibitor | |||
| 0.149 | 0.076 | 0.149 | Acetylcholine M1 receptor antagonist | 0.146 0.078 CHEMBL255839 | ||
| 0.099 | 0.028 | 0.099 | Dopamine agonist | 0.08 0.037 CHEMBL255839 | ||
| 0.269 | 0.202 | 0.269 | 5 Hydroxytryptamine release inhibitor | 0.255 0.221 CHEMBL255839 | ||
| 0.078 | 0.015 | 0.078 | Dopamine D2 agonist | 0.056 0.023 CHEMBL255839 0.044 0.031 CHEMBL4525799 0.078 0.015 CHEMBL3526616 | ||
| 0.069 | 0.006 | 0.069 | 5-Alpha-reductase 1 inhibitor | 0.015 0.013 CHEMBL255839 0.016 0.012 CHEMBL4525799 | ||
| 0.081 | 0.019 | 0.099 | Protein kinase C epsilon inhibitor | 0.099 0.013 CHEMBL255839 | CHEMBL255839 | |
| 0.146 | 0.084 | 0.165 | Anticoagulant | 0.165 0.069 CHEMBL255839 0.163 0.07 CHEMBL3526616 | CHEMBL255839 | |
| 0.085 | 0.024 | 0.085 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 CHEMBL255839 | ||
| 0.096 | 0.037 | 0.101 | Somatostatin 1 agonist | 0.101 0.034 CHEMBL255839 | CHEMBL255839 | |
| 0.139 | 0.082 | 0.293 | Hemostatic | 0.138 0.083 CHEMBL255839 0.293 0.016 CHEMBL3526616 | CHEMBL3526616 | |
| 0.093 | 0.036 | 0.17 | 5 Hydroxytryptamine agonist | 0.17 0.018 CHEMBL255839 | CHEMBL255839 | |
| 0.068 | 0.014 | 0.068 | 5-Alpha-reductase inhibitor | 0.035 0.028 CHEMBL255839 0.053 0.018 CHEMBL4525799 | ||
| 0.06 | 0.009 | 0.06 | Opioid delta receptor agonist | 0.06 0.009 CHEMBL4525799 | ||
| 0.173 | 0.126 | 0.19 | 5 Hydroxytryptamine 3E antagonist | 0.19 0.081 CHEMBL255839 | CHEMBL255839 | |
| 0.164 | 0.118 | 0.164 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.053 | 0.009 | 0.057 | Factor XI inhibitor | 0.057 0.008 CHEMBL255839 | CHEMBL255839 | |
| 0.101 | 0.061 | 0.101 | Anabolic | 0.092 0.074 CHEMBL255839 | ||
| 0.113 | 0.074 | 0.113 | Acetylcholine muscarinic antagonist | 0.111 0.078 CHEMBL255839 0.097 0.094 CHEMBL4525799 | ||
| 0.269 | 0.23 | 0.269 | Caspase 9 stimulant | 0.268 0.231 CHEMBL3526616 | ||
| 0.13 | 0.091 | 0.13 | Peroxidase inhibitor | |||
| 0.061 | 0.024 | 0.061 | Dipeptidyl peptidase inhibitor | 0.053 0.035 CHEMBL255839 | ||
| 0.096 | 0.063 | 0.096 | Electrolyte absorption antagonist | 0.094 0.066 CHEMBL255839 | ||
| 0.162 | 0.129 | 0.162 | Aldehyde oxidase inhibitor | |||
| 0.098 | 0.065 | 0.16 | GABA C receptor rho-1 antagonist | 0.16 0.017 CHEMBL255839 | CHEMBL255839 | |
| 0.102 | 0.069 | 0.102 | Ferrochelatase inhibitor | 0.088 0.086 CHEMBL255839 | ||
| 0.051 | 0.02 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.044 0.032 CHEMBL255839 | ||
| 0.08 | 0.051 | 0.08 | Na+ K+ transporting ATPase inhibitor | 0.075 0.055 CHEMBL255839 0.067 0.063 CHEMBL3526616 | ||
| 0.087 | 0.059 | 0.087 | Histamine N-methyltransferase inhibitor | |||
| 0.067 | 0.039 | 0.067 | Acetylcholine M2 receptor antagonist | 0.062 0.043 CHEMBL255839 | ||
| 0.078 | 0.05 | 0.078 | CYP2A6 inhibitor | 0.075 0.053 CHEMBL255839 | ||
| 0.05 | 0.024 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.012 CHEMBL3526616 | CHEMBL3526616 | |
| 0.109 | 0.084 | 0.109 | Cholinergic antagonist | |||
| 0.143 | 0.12 | 0.143 | Neurotensin receptor agonist | 0.14 0.129 CHEMBL255839 | ||
| 0.042 | 0.021 | 0.049 | 5 Hydroxytryptamine 2B agonist | 0.049 0.014 CHEMBL255839 | CHEMBL255839 | |
| 0.062 | 0.043 | 0.062 | Prolactin release inhibitor | |||
| 0.057 | 0.038 | 0.057 | Kallikrein 1 inhibitor | 0.056 0.04 CHEMBL255839 | ||
| 0.038 | 0.02 | 0.05 | Plasma kallikrein inhibitor | 0.05 0.012 CHEMBL255839 | CHEMBL255839 | |
| 0.039 | 0.023 | 0.042 | Tryptase inhibitor | 0.042 0.02 CHEMBL255839 | CHEMBL255839 | |
| 0.037 | 0.025 | 0.037 | Kinesin-like protein 1 inhibitor | |||
| 0.037 | 0.025 | 0.037 | Kinesin antagonist | |||
| 0.133 | 0.122 | 0.133 | Tumour necrosis factor antagonist | |||
| 0.025 | 0.015 | 0.034 | Glutamate (mGluR1) agonist | 0.034 0.007 CHEMBL255839 | CHEMBL255839 | |
| 0.173 | 0.163 | 0.236 | DNA synthesis inhibitor | 0.21 0.108 CHEMBL255839 0.236 0.077 CHEMBL3526616 | CHEMBL3526616 | |
| 0.106 | 0.096 | 0.106 | Cathepsin H inhibitor | |||
| 0.099 | 0.09 | 0.099 | TRPA1 agonist | |||
| 0.066 | 0.058 | 0.068 | Aminopeptidase I inhibitor | 0.068 0.056 CHEMBL255839 | CHEMBL255839 | |
| 0.044 | 0.036 | 0.054 | Kallikrein inhibitor | 0.054 0.027 CHEMBL255839 | CHEMBL255839 | |
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.009 CHEMBL4525799 | ||
| 0.08 | 0.073 | 0.08 | Hematopoietic | |||
| 0.079 | 0.072 | 0.087 | Estrogen-related receptor beta agonist | 0.087 0.047 CHEMBL255839 | CHEMBL255839 | |
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.016 | 0.01 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 CHEMBL255839 | CHEMBL255839 | |
| 0.037 | 0.032 | 0.041 | Membrane dipeptidase inhibitor | 0.041 0.025 CHEMBL255839 | CHEMBL255839 | |
| 0.089 | 0.086 | 0.109 | Glutamate (mGluR7) agonist | 0.109 0.043 CHEMBL255839 | CHEMBL255839 | |
| 0.053 | 0.05 | 0.053 | Acetylcholine M3 receptor antagonist | 0.053 0.05 CHEMBL4525799 | ||
| 0.122 | 0.121 | 0.188 | GABA C receptor rho-2 antagonist | 0.188 0.036 CHEMBL255839 | CHEMBL255839 | |
| 0.03 | 0.028 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 CHEMBL255839 | CHEMBL255839 | |
| 0.159 | 0.158 | 0.159 | DNA damaging | |||
| 0.079 | 0.078 | 0.091 | Protein kinase C delta inhibitor | 0.091 0.061 CHEMBL255839 | CHEMBL255839 | |
| 0.025 | 0.025 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 CHEMBL255839 | CHEMBL255839 | |
| 0.044 | 0.044 | 0.057 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 CHEMBL255839 | CHEMBL255839 | |
| 0.073 | 0.075 | 0.1 | Ornithine decarboxylase inhibitor | 0.1 0.045 CHEMBL255839 | CHEMBL255839 | |
| 0.071 | 0.073 | 0.116 | Glycine receptor antagonist | 0.116 0.02 CHEMBL3526616 | CHEMBL3526616 | |
| 0.082 | 0.084 | 0.106 | Sphingomyelinase inhibitor | 0.106 0.053 CHEMBL4525799 0.093 0.068 CHEMBL3526616 | CHEMBL4525799 | |
| 0.092 | 0.095 | 0.158 | DNA polymerase I inhibitor | 0.118 0.07 CHEMBL255839 0.158 0.045 CHEMBL3526616 | CHEMBL3526616 | |
| 0.031 | 0.036 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 CHEMBL3526616 | CHEMBL3526616 | |
| 0.037 | 0.05 | 0.044 | Histamine H1 receptor agonist | 0.044 0.03 CHEMBL255839 | CHEMBL255839 | |
| 0.054 | 0.067 | 0.057 | Trypsin inhibitor | 0.057 0.056 CHEMBL255839 | CHEMBL255839 | |
| 0.023 | 0.037 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.013 CHEMBL255839 | CHEMBL255839 | |
| 0.046 | 0.061 | 0.053 | Epithelial sodium channel blocker | 0.053 0.042 CHEMBL255839 | CHEMBL255839 | |
| 0.117 | 0.132 | 0.16 | Adenylate cyclase stimulant | 0.143 0.074 CHEMBL255839 0.16 0.048 CHEMBL4525799 0.151 0.061 CHEMBL3526616 | CHEMBL4525799 | |
| 0.019 | 0.035 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 CHEMBL4525799 | CHEMBL4525799 | |
| 0.015 | 0.036 | 0.026 | Lysophosphatidic acid 1 receptor antagonist | 0.026 0.008 CHEMBL4525799 | CHEMBL4525799 | |
| 0.096 | 0.119 | 0.128 | Nav1.2 sodium channel blocker | 0.128 0.074 CHEMBL255839 | CHEMBL255839 | |
| 0.09 | 0.113 | 0.103 | Calcium channel N-type blocker | 0.103 0.091 CHEMBL255839 | CHEMBL255839 | |
| 0.106 | 0.136 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.085 CHEMBL255839 | CHEMBL255839 | |
| 0.039 | 0.072 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.02 CHEMBL3526616 | CHEMBL3526616 | |
| 0.015 | 0.05 | 0.032 | Protein 30S ribosomal subunit inhibitor | 0.032 0.012 CHEMBL3526616 | CHEMBL3526616 | |
| 0.025 | 0.06 | 0.051 | Vascular adhesion protein 1 inhibitor | 0.051 0.014 CHEMBL255839 | CHEMBL255839 | |
| 0.024 | 0.061 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 CHEMBL255839 | CHEMBL255839 | |
| 0.058 | 0.097 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.047 CHEMBL255839 | CHEMBL255839 | |
| 0.173 | 0.215 | 0.511 | Antithrombotic | 0.511 0.028 CHEMBL3526616 | CHEMBL3526616 | |
| 0.04 | 0.083 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 CHEMBL255839 | CHEMBL255839 | |
| 0.043 | 0.087 | 0.063 | Sphingosine kinase inhibitor | 0.063 0.033 CHEMBL255839 | CHEMBL255839 | |
| 0.07 | 0.122 | 0.096 | Alpha 2b adrenoreceptor antagonist | 0.096 0.078 CHEMBL255839 | CHEMBL255839 | |
| 0.026 | 0.081 | 0.055 | Mannosidase inhibitor | 0.055 0.02 CHEMBL3526616 | CHEMBL3526616 | |
| 0.011 | 0.066 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 CHEMBL3526616 | CHEMBL3526616 | |
| 0.065 | 0.121 | 0.106 | NADH dehydrogenase inhibitor | 0.106 0.038 CHEMBL3526616 | CHEMBL3526616 | |
| 0.08 | 0.138 | 0.15 | Alpha-N-acetylglucosaminidase inhibitor | 0.15 0.055 CHEMBL3526616 | CHEMBL3526616 | |
| 0.049 | 0.109 | 0.069 | Phospholipase D inhibitor | 0.069 0.055 CHEMBL255839 | CHEMBL255839 | |
| 0.073 | 0.137 | 0.143 | Nav1.3 sodium channel blocker | 0.143 0.053 CHEMBL255839 | CHEMBL255839 | |
| 0.121 | 0.187 | 0.457 | Immunostimulant | 0.169 0.14 CHEMBL4525799 0.457 0.035 CHEMBL3526616 | CHEMBL3526616 | |
| 0.047 | 0.117 | 0.061 | Histone deacetylase SIRT3 inhibitor | 0.061 0.047 CHEMBL255839 | CHEMBL255839 | |
| 0.026 | 0.108 | 0.05 | Adenylate cyclase 1 inhibitor | 0.05 0.026 CHEMBL4525799 | CHEMBL4525799 | |
| 0.145 | 0.229 | 0.187 | Nitric-oxide synthase stimulant | 0.187 0.112 CHEMBL255839 | CHEMBL255839 | |
| 0.038 | 0.123 | 0.057 | Heat shock protein 90 beta antagonist | 0.057 0.045 CHEMBL255839 | CHEMBL255839 | |
| 0.078 | 0.174 | 0.131 | Histone deacetylase SIRT1 inhibitor | 0.131 0.079 CHEMBL255839 | CHEMBL255839 | |
| 0.02 | 0.116 | 0.03 | DNA topoisomerase IV inhibitor | 0.03 0.02 CHEMBL255839 | CHEMBL255839 | |
| 0.071 | 0.17 | 0.19 | Cyclooxygenase 3 inhibitor | 0.19 0.023 CHEMBL3526616 | CHEMBL3526616 | |
| 0.144 | 0.246 | 0.26 | Immunomodulator | 0.26 0.107 CHEMBL3526616 | CHEMBL3526616 | |
| 0.098 | 0.204 | 0.151 | Interferon gamma antagonist | 0.151 0.077 CHEMBL3526616 | CHEMBL3526616 | |
| 0.033 | 0.143 | 0.081 | Neuraminidase (influenza) inhibitor | 0.081 0.025 CHEMBL3526616 | CHEMBL3526616 | |
| 0.06 | 0.171 | 0.103 | Proteasome inhibitor | 0.103 0.083 CHEMBL255839 | CHEMBL255839 | |
| 0.043 | 0.155 | 0.088 | Heme oxygenase stimulant | 0.088 0.011 CHEMBL255839 | CHEMBL255839 | |
| 0.077 | 0.19 | 0.118 | Protein kinase stimulant | 0.118 0.094 CHEMBL3526616 | CHEMBL3526616 | |
| 0.057 | 0.183 | 0.101 | Alkylator | 0.101 0.087 CHEMBL3526616 | CHEMBL3526616 | |
| 0.047 | 0.173 | 0.08 | Histamine H2 receptor antagonist | 0.08 0.065 CHEMBL255839 | CHEMBL255839 | |
| 0.021 | 0.147 | 0.076 | Neuraminidase inhibitor | 0.076 0.028 CHEMBL3526616 | CHEMBL3526616 | |
| 0.026 | 0.155 | 0.091 | Potassium channel Kv1.5 blocker | 0.091 0.021 CHEMBL4525799 | CHEMBL4525799 | |
| 0.13 | 0.26 | 0.324 | Peptidyltransferase inhibitor | 0.324 0.018 CHEMBL3526616 | CHEMBL3526616 | |
| 0.035 | 0.165 | 0.081 | Epoxide hydrolase inhibitor | 0.081 0.04 CHEMBL255839 | CHEMBL255839 | |
| 0.141 | 0.274 | 0.194 | Insulysin inhibitor | 0.194 0.166 CHEMBL255839 | CHEMBL255839 | |
| 0.1 | 0.235 | 0.221 | Tumour necrosis factor alpha release inhibitor | 0.167 0.137 CHEMBL255839 0.221 0.092 CHEMBL3526616 | CHEMBL3526616 | |
| 0.128 | 0.264 | 0.427 | Cholesterol antagonist | 0.427 0.044 CHEMBL3526616 | CHEMBL3526616 | |
| 0.039 | 0.179 | 0.058 | Lipocortins synthesis agonist | 0.058 0.04 CHEMBL3526616 | CHEMBL3526616 | |
| 0.152 | 0.292 | 0.403 | Interleukin 2 agonist | 0.403 0.026 CHEMBL3526616 | CHEMBL3526616 | |
| 0.092 | 0.238 | 0.152 | Antipruritic | 0.152 0.092 CHEMBL255839 | CHEMBL255839 | |
| 0.057 | 0.214 | 0.195 | Thrombolytic | 0.122 0.108 CHEMBL255839 0.195 0.054 CHEMBL3526616 | CHEMBL3526616 | |
| 0.041 | 0.204 | 0.093 | Expectorant | 0.093 0.076 CHEMBL3526616 | CHEMBL3526616 | |
| 0.126 | 0.29 | 0.277 | Vasodilator, coronary | 0.277 0.108 CHEMBL3526616 | CHEMBL3526616 | |
| 0.034 | 0.202 | 0.213 | Topoisomerase I inhibitor | 0.213 0.023 CHEMBL3526616 | CHEMBL3526616 | |
| 0.018 | 0.188 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.083 0.018 CHEMBL3526616 | CHEMBL3526616 | |
| 0.091 | 0.266 | 0.215 | Vasodilator | 0.215 0.093 CHEMBL3526616 | CHEMBL3526616 | |
| 0.041 | 0.231 | 0.084 | UDP-glucose 4-epimerase inhibitor | 0.084 0.083 CHEMBL3526616 | CHEMBL3526616 | |
| 0.033 | 0.226 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.031 CHEMBL3526616 | CHEMBL3526616 | |
| 0.159 | 0.364 | 0.248 | Calcium channel L-type activator | 0.248 0.207 CHEMBL4525799 | CHEMBL4525799 | |
| 0.074 | 0.284 | 0.214 | Antiamyloidogenic | 0.214 0.091 CHEMBL3526616 | CHEMBL3526616 | |
| 0.049 | 0.267 | 0.136 | Microtubule formation inhibitor | 0.136 0.046 CHEMBL3526616 | CHEMBL3526616 | |
| 0.018 | 0.243 | 0.042 | VCAM antagonist | 0.042 0.02 CHEMBL255839 | CHEMBL255839 | |
| 0.018 | 0.243 | 0.042 | VCAM-1 antagonist | 0.042 0.02 CHEMBL255839 | CHEMBL255839 | |
| 0.039 | 0.273 | 0.113 | AMP-activated protein kinase stimulant | 0.113 0.055 CHEMBL3526616 | CHEMBL3526616 | |
| 0.029 | 0.265 | 0.089 | Protease inhibitor | 0.089 0.075 CHEMBL3526616 | CHEMBL3526616 | |
| 0.012 | 0.251 | 0.128 | Antineoplastic antibiotic | 0.128 0.036 CHEMBL3526616 | CHEMBL3526616 | |
| 0.037 | 0.289 | 0.098 | Beta glucuronidase inhibitor | 0.098 0.073 CHEMBL3526616 | CHEMBL3526616 | |
| 0.106 | 0.371 | 0.212 | Sodium/bile acid cotransporter inhibitor | 0.212 0.172 CHEMBL4525799 | CHEMBL4525799 | |
| 0.061 | 0.34 | 0.301 | Hepatoprotectant | 0.301 0.029 CHEMBL3526616 | CHEMBL3526616 | |
| 0.052 | 0.352 | 0.295 | Nitric oxide antagonist | 0.295 0.041 CHEMBL3526616 | CHEMBL3526616 | |
| 0.073 | 0.377 | 0.264 | Transcription factor NF kappa B inhibitor | 0.264 0.117 CHEMBL3526616 | CHEMBL3526616 | |
| 0.026 | 0.331 | 0.202 | Topoisomerase II inhibitor | 0.202 0.033 CHEMBL3526616 | CHEMBL3526616 | |
| 0.04 | 0.36 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 CHEMBL3526616 | CHEMBL3526616 | |
| 0.038 | 0.372 | 0.459 | Angiogenesis stimulant | 0.459 0.015 CHEMBL3526616 | CHEMBL3526616 | |
| 0.087 | 0.424 | 0.214 | Toll-Like receptor agonist | 0.214 0.185 CHEMBL4525799 | CHEMBL4525799 | |
| 0.014 | 0.351 | 0.076 | DNA gyrase inhibitor | 0.076 0.03 CHEMBL255839 | CHEMBL255839 | |
| 0.009 | 0.372 | 0.053 | Microtubule stabilization | 0.053 0.023 CHEMBL3526616 | CHEMBL3526616 | |
| 0.08 | 0.451 | 0.205 | Toll-Like receptor 7 agonist | 0.205 0.195 CHEMBL4525799 | CHEMBL4525799 | |
| 0.073 | 0.47 | 0.514 | Antibacterial | 0.514 0.037 CHEMBL3526616 | CHEMBL3526616 | |
| 0.016 | 0.418 | 0.05 | Heparanase inhibitor | 0.05 0.044 CHEMBL3526616 | CHEMBL3526616 | |
| 0.008 | 0.426 | 0.255 | Selectin antagonist | 0.255 0.008 CHEMBL3526616 | CHEMBL3526616 | |
| 0.02 | 0.444 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.074 CHEMBL3526616 | CHEMBL3526616 | |
| 0.011 | 0.461 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.021 CHEMBL3526616 | CHEMBL3526616 | |
| 0.073 | 0.539 | 0.323 | Apoptosis antagonist | 0.323 0.071 CHEMBL3526616 | CHEMBL3526616 | |
| 0.003 | 0.47 | 0.057 | Cholecystokinin B antagonist | 0.057 0.009 CHEMBL4525799 | CHEMBL4525799 | |
| 0.003 | 0.503 | 0.097 | Cholecystokinin A antagonist | 0.097 0.009 CHEMBL4525799 | CHEMBL4525799 | |
| 0.043 | 0.543 | 0.481 | Immunosuppressant | 0.481 0.038 CHEMBL3526616 | CHEMBL3526616 | |
| 0.024 | 0.564 | 0.126 | Toll-Like receptor 4 antagonist | 0.126 0.038 CHEMBL3526616 | CHEMBL3526616 | |
| 0.004 | 0.548 | 0.099 | Leukotriene A4 hydrolase inhibitor | 0.099 0.006 CHEMBL4525799 | CHEMBL4525799 | |
| 0.021 | 0.569 | 0.174 | Platelet antagonist | 0.174 0.122 CHEMBL3526616 | CHEMBL3526616 | |
| 0.004 | 0.576 | 0.071 | Cholecystokinin antagonist | 0.071 0.014 CHEMBL4525799 | CHEMBL4525799 | |
| 0.012 | 0.585 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 CHEMBL3526616 | CHEMBL3526616 | |
| 0.011 | 0.586 | 0.116 | Topoisomerase II alpha inhibitor | 0.116 0.031 CHEMBL3526616 | CHEMBL3526616 | |
| 0.013 | 0.6 | 0.16 | Lipid peroxidase inhibitor | 0.16 0.062 CHEMBL3526616 | CHEMBL3526616 | |
| 0.071 | 0.663 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.116 CHEMBL3526616 | CHEMBL3526616 | |
| 0.021 | 0.613 | 0.356 | Antioxidant | 0.356 0.045 CHEMBL3526616 | CHEMBL3526616 | |
| 0.014 | 0.638 | 0.304 | Free radical scavenger | 0.304 0.051 CHEMBL3526616 | CHEMBL3526616 | |
| 0.043 | 0.67 | 0.418 | Apoptosis agonist | 0.267 0.198 CHEMBL4525799 0.418 0.105 CHEMBL3526616 | CHEMBL3526616 | |
| 0.032 | 0.716 | 0.441 | Cyclophilin D inhibitor | 0.441 0.071 CHEMBL3526616 | CHEMBL3526616 | |
| 0.013 | 0.73 | 0.157 | Cell adhesion inhibitor | 0.157 0.042 CHEMBL3526616 | CHEMBL3526616 | |
| 0.009 | 0.727 | 0.19 | Hypolipemic | 0.19 0.102 CHEMBL3526616 | CHEMBL3526616 | |
| 0.03 | 0.749 | 0.122 | NOS3 expression enhancer | 0.122 0.112 CHEMBL3526616 | CHEMBL3526616 | |
| 0.029 | 0.767 | 0.573 | Antiinflammatory | 0.573 0.061 CHEMBL3526616 | CHEMBL3526616 | |
| 0.006 | 0.747 | 0.076 | Cell adhesion molecule inhibitor | 0.076 0.059 CHEMBL3526616 | CHEMBL3526616 | |
| 0.016 | 0.786 | 0.276 | Platelet adhesion inhibitor | 0.276 0.041 CHEMBL3526616 | CHEMBL3526616 | |
| 0.009 | 0.901 | 0.311 | Hypoglycemic | 0.311 0.049 CHEMBL3526616 | CHEMBL3526616 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |